Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression
Mai O. Kadry, Ahmed Serag, Naglaa M. Ammar
TL;DR
This study shows that liposomal Resvida improves endometrial cancer treatment by regulating autophagy-related genes and altering metabolite profiles.
Contribution
The study introduces liposomal Resvida as a novel drug delivery system that modulates autophagy and improves EC treatment outcomes.
Findings
Liposomal Resvida significantly reduced CA125 levels and altered key autophagy-related gene expressions.
Metabolomic analysis revealed distinct serum chemical profiles in Resvida and liposomal Resvida treated groups.
Liposomal delivery showed greater efficacy in modulating autophagy genes compared to standard Resvida treatment.
Abstract
Endometrial cancer (EC) is the fourth most abundant gynecological cancer. There is an increase in the incidence of mortality from uterine cancers in the past few decades. A comprehensive systematic study to provide an overview on the relationship between autophagy, metabolomics and the risk of oestradiol valerate (OV) induced endometrial cancer was conducted correlated with the use of liposomal loaded-resvida as an innovate drug delivery system. This article explores how metabolomic technology can offer valuable insights on autophagy molecular aspects in EC by identifying new possible metabolite biomarkers that has the potential to improve the accuracy of diagnosis, prognosis and disease monitoring. Metabolomics approach, included orthogonal partial least squares discriminant analysis (OPLS-DA), thus revolutionizes the management of endometrial cancer. Autophagy described in endometrial…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 10
Figure 11
Figure 12
Figure 13
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 7
Figure 7
Figure 8
Figure 9
Figure 16
Figure 17Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEndometrial and Cervical Cancer Treatments · Metabolomics and Mass Spectrometry Studies · Autophagy in Disease and Therapy